Urinary side effects of psychotropic drugs: A systematic review and metanalysis. Issue 6 (18th May 2021)

• Record Type: Journal Article
• Authors: Trinchieri, Margherita; Perletti, Gianpaolo; Magri, Vittorio; Stamatiou, Konstantinos; Montanari, Emanuele; Trinchieri, Alberto
• Is Part Of: Neurourology and urodynamics. Volume 40:Issue 6(2021)
• Page Start: 1333
• Page End: 1348
• Publication Date: 2021-05-18
• Subjects: antidepressants -- antipsychotics -- urinary disorders -- urinary retention; Urinary organs -- Periodicals; Urodynamics -- Periodicals; Urology -- Periodicals; 616.6
• DOI: 10.1002/nau.24695
• Languages: English
• ISSNs: 0733-2467

Abstract

Abstract: Objective: To evaluate the effects of psychotropic drugs on bladder function. Materials and Methods: A systematic review was carried out by searching PubMed and Embase databases for randomized controlled trials enrolling patients treated with psychotropic drugs with available information on treatment‐related urinary disorders. Results: A total of 52 studies was selected. In antidepressant therapy, bladder voiding symptoms, rather than storage symptoms, were more frequently observed. Pooled analysis demonstrated a higher odds ratio (OR) of voiding disorders in comparison with placebo (OR: 3.30; confidence interval [CI]: 1.90–5.72; 7856 participants; p < 0.001). Odds for voiding dysfunction was higher for tricyclic antidepressants and for Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) when compared to Selective Serotonin Reuptake Inhibitors (SSRIs). Treatment with antipsychotics was associated with heterogeneous urinary disorders including emptying and storage disorders. OR for incontinence in patients with dementia taking antipsychotics was higher than placebo (OR: 4.09; CI: 1.71–9.79, p = 0.002) with no difference between different atypical antipsychotics. Rate of voiding disorders was not different between conventional and atypical antipsychotics (OR: 1.64; CI: 0.79–3.39, p = 0.19), although quetiapine showed higher odds to cause voiding dysfunction than other atypical antipsychotics (OR: 2.14; CI: 1.41–3.26; p > 0.001). Conclusions: In patients taking tricyclic antidepressants or SNRIs, bladder voiding disorders, could be the side effects of therapy rather than symptoms of a urological disease. Patients treated with these drugs should be actively monitored for the appearance of urinary symptoms. Antipsychotic treatment is associated with various urinary side effects requiring a tailored approach.